News
-
FDA to look towards Observer Status in Avicenna Alliance
The Avicenna Alliance has been in touch with the FDA on the issue of in silico medicine over the last number of months and has reached a new level of cooperation with the FDA looking into Observer Status in the Avicenna Alliance.
-Read more-
-
Avicenna Alliance meets with European Commission for review in silico medicine
On 02 May 2016, Avicenna Alliance delegates met with representatives of DG Connect to discuss progress on in silico medicine in the 1st quarter of this year.
-Read more-
-
Written declaration of the European Parliament on electronic health records
The European Parliament has forwarded a written declaration (i.e. a very short non-binding statement of will) on electronic health records to the Council and the Commission, on 27 April 2016.
-Read more-
-
Kick-off meeting of the Commission's new scientific committees
On 28 April 2016, the newly appointed scientists who are to provide the European Commission with independent scientific advice on issues relating to consumer safety, public health and the environment during their five year mandate (2016-2021), hold their inaugural meeting in Luxembourg.
-Read more-
-
Report on strategies across Europe to assess quality of care
The expert group on Health Systems Performance Assessment (HSPA) published its first report on 29 April 2016: "So What? Strategies across Europe to assess quality of care".
-Read more-
-
Public consultation on Horizon 2020 Work Programme 2018-2020
A public online consultation has been launched by the European Commission’s DG Research and Innovation, on the strategy, scope, objectives, and expected impacts of the Horizon 2020 ‘Science with and for Society’ (SWAFS) Work Programme 2018-2020.
-Read more-
